MSB 7.69% $1.19 mesoblast limited

Ann: Circulation Publishes Improved Outcomes with Mesoblast Cells, page-3

  1. 4,633 Posts.
    lightbulb Created with Sketch. 694

    Angelus512 - 1) it's all just data gathering and very good data for MSB, in more ways than one, if our stuff shows more more safety in the heart - directly - that'll likely speed up all our approvals!

    2) I've always thought an interesting application, would be the ability to give our cells to a healthy, say middle aged person, to prevent heart issues as they age, HUGE market and potentially great savings for the health system - this is a step maybe down that path, with low dose testing...one day!
    Last edited by Moreforme: 25/06/14
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.